At the IMF, we believe that diversity and inclusion are integral aspects of the myeloma community. Myeloma knows no borders—people all over the world and from all different walks of life are diagnosed with this disease.
The IMF's Diversity Policy
We strive to include all people at IMF events and programs. The members of the myeloma community are diverse not only in gender, race, ethnicity, sexual orientation, disability, religion, and age, but also in cultural backgrounds, life experiences, thoughts, and ideas.
We ask that groups who feel they are underrepresented or misrepresented in the myeloma community give voice to their concerns. We are here to listen. We are here to provide a second home for all.
We encourage you to learn more to be an empowered member of our One Myeloma Nation.
We know more research is needed to understand how and why myeloma affects African Americans the way it does. Under the guidance of our Chief Medical Officer, Dr. Joseph Mikhael, the IMF is committed to pursuing these questions in the coming year.
Join us at diversity.myeloma.org to sign up for our mailing list so that you can be the first to know of any new developments, studies, or programs that may affect you and your loved ones in the African-American community.
with educational support from:
Amgen, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Takeda Oncology and The Binding Site